Financhill
Buy
72

NI Quote, Financials, Valuation and Earnings

Last price:
$38.95
Seasonality move :
3.91%
Day range:
$39.24 - $39.98
52-week range:
$26.26 - $41.45
Dividend yield:
2.73%
P/E ratio:
24.15x
P/S ratio:
3.29x
P/B ratio:
2.13x
Volume:
4.8M
Avg. volume:
4.8M
1-year change:
48.53%
Market cap:
$18.5B
Revenue:
$5.5B
EPS (TTM):
$1.63

NI Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for NiSource shares anticipate an average target of $41.13, ranging from a low estimate of $35.00 to a high estimate of $48.15. This average target implies a growth of 4.5% compared to the current stock price of $39.36.

Consensus Price Target

$41.13

Highest Price Target

$48.15

Lowest Price Target

$35.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 8 10 11

Hold 1 1 1

Sell 0 0 0
Consensus Buy Buy Buy

NI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock